GOSR1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-69181
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Summary for GOSR1 Antibody
Immunogen
Synthetic peptides corresponding to GOSR1 (golgi SNAP receptor complex member 1) The peptide sequence was selected form the C terminal of GOSR1. Peptide sequence IHSKMNTLANRFPAVNSLIQRINLRKRRDSLILGGVIGICTILLLLYAFH. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for GOSR1 Antibody
Western Blot: GOSR1 Antibody [NBP1-69181]
Western Blot: GOSR1 Antibody [NBP1-69181] - Titration: 0.2-1 ug/ml, Positive Control: Human Liver.Applications for GOSR1 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: GOSR1/GS28
Long Name
Golgi SNAP Receptor Complex Member 1
Alternate Names
GOLIM2, GS28, p28
Gene Symbol
GOSR1
OMIM
NP_004862 (Human)
UniProt
Additional GOSR1/GS28 Products
Product Documents for GOSR1 Antibody
Product Specific Notices for GOSR1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...